- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Oxidative Medicine and Cellular Longevity
Volume 2013 (2013), Article ID 649809, 11 pages
Enhanced Prostacyclin Synthesis by Adenoviral Gene Transfer Reduced Glial Activation and Ameliorated Dopaminergic Dysfunction in Hemiparkinsonian Rats
1Neural Regeneration Laboratory, Department of Neurosurgery, Neurological Institute, Taipei Veterans General Hospital, Taipei 11221, Taiwan
2Center for Neural Regeneration, Neurological Institute, Taipei Veterans General Hospital, Taipei 11221, Taiwan
3Institute of Biotechnology, National Dong Hwa University, Hualien 97401, Taiwan
4School of Medicine, National Yang-Ming University, Taipei 11221, Taiwan
5Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan
6Department of Pharmacology, National Yang-Ming University, Taipei 11221, Taiwan
Received 9 December 2012; Revised 10 February 2013; Accepted 18 February 2013
Academic Editor: Anantharaman Muthuswamy
Copyright © 2013 May-Jywan Tsai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Prostacyclin (PGI2), a potent vasodilator and platelet antiaggregatory eicosanoid, is cytoprotective in cerebral circulation. It is synthesized from arachidonic acid (AA) by the sequential action of cyclooxygenase- (COX-) 1 or 2 and prostacyclin synthase (PGIS). Because prostacyclin is unstable in vivo, PGI2 analogs have been developed and demonstrated to protect against brain ischemia. This work attempts to selectively augment PGI2 synthesis in mixed glial culture or in a model of Parkinson’s disease (PD) by direct adenoviral gene transfer of prostacyclin biosynthetic enzymes and examines whether it confers protection in cultures or in vivo. Confluent mixed glial cultures actively metabolized exogenous AA into PGE2 and PGD2. These PGs were largely NS398 sensitive and considered as COX-2 products. Gene transfer of AdPGIS to the cultures effectively shunted the AA catabolism to prostacyclin synthesis and concurrently reduced cell proliferation. Furthermore, PGIS overexpression significantly reduced LPS stimulation in cultures. In vivo, adenoviral gene transfer of bicistronic COX-1/PGIS to substantia nigra protected 6-OHDA- induced dopamine depletion and ameliorated behavioral deficits. Taken together, this study shows that enhanced prostacyclin synthesis reduced glial activation and ameliorated motor dysfunction in hemiparkinsonian rats. Prostacyclin may have a neuroprotective role in modulating the inflammatory response in degenerating nigra-striatal pathway.
Parkinson’s disease (PD) is characterized by the progressive degeneration of nigrostriatal dopaminergic (DA) accompanied with inflammatory changes leading to activation of microglia and astrocytes . The substantia nigra (SN) of the brain is particularly rich in microglia [2, 3]. In addition, dopaminergic neurons in the SN have a reduced antioxidant capacity, rendering them vulnerable to a variety of insult. Inflammatory responses are also associated with the effects of dopaminergic neurotoxins, 6-hydroxydopamine (6-OHDA) or 1-methyl-4-pheny-1,2,3,6-tetrahydropyridine (MPTP). Activated microglia and DA cell loss were found in the primate SN years after MPTP treatment . In the striatum and SN of 6-OHDA-lesioned rat brains, prominent microglial activation was detectable weeks after the lesion . Intranigral injection of LPS in rats also resulted in microglial activation and degeneration of the DA system [6, 7]. Whether microglial activation protects or exacerbates neuronal loss is presently debated, though most studies suggest that activated microglia exerts a toxic effect on neurons.
The prostanoids, a naturally occurring subclass of eicosanoids, are lipid mediators generated through the oxidative metabolism of 20-carbon fatty acids (eicosa is Greek for 20), primarily arachidonic acid (AA). Prostaglandins (PGs), synthesized from AA by cyclooxygenases (COXs), have diverse biological actions by working as local mediators. In the central nervous system (CNS), PGs maintain important functions as retrograde synaptic messengers and as early mediators of neuronal injury. The levels of PG production are mediated by the expression and activity of COX. COX exists in two distinct isoforms, constitutive COX-1 and inducible COX-2. COX-2 is responsible for the increased production of prostanoids during inflammation and stress [8, 9]. In the brain, COX-2 is constitutively expressed and is also the dominating COX isoform [10, 11] that mainly produces PGE2 and PGD2 [12, 13]. Prostacyclin (PGI2), synthesized by sequential action of COX and prostacyclin synthase (PGIS), is a potent endogenous inhibitor of platelet aggregation. It inhibits platelet secretory activity and aggregation, maintains vasorelaxation, blocks monocyte-vascular wall interactions and is vasoprotective . Because of its instability in vivo, several PGI2 analogs have been developed and demonstrated to reduce ischemic brain damage [15–17].
Our previous results have shown that overexpression of COX-1 and PGIS was able to generate large quantity of PGI2 in human endothelial cells . Using adenovirus-mediated transfer of COX1 or COX1/PGIS, Lin et al.,  and our coworkers  have demonstrated that enhanced PGI2 synthesis in neuronal cultures or in ischemic brain was neuroprotective and had prominent influence on microglia. This work attempts to selectively augment PGI2 synthesis in mixed glial culture and in hemiparkinsonian rats by direct adenoviral gene transfer of PGIS or bicistronic COX-1/PGIS and examines whether it confers protection or induces cell damage in Parkinson’s disease (PD). Hemiparkinsonian rats were induced by injection of 6-OHDA to middle forebrain bundle (MFB), the ascending pathway of nigrostriatal system. Our results demonstrated that enhanced prostacyclin synthesis inhibited glial activation and was beneficial in hemiparkinsonian rats.
2. Materials and Methods
Lipopolysaccharide (LPS; E. coli 0111:B4), OHDA, dopamine, apomorphine and methylthiazol tetrazolium (MTT) were obtained from Sigma-Aldrich (St. Louis, MO). CAY10449 was purchased from Cayman Chemical (Ann Arbor, MI). Cultured media and antibiotics were purchased from Invitrogen (Carlsbad, CA, USA). [6-3H] thymidine, [1-14C] arachidonic acid (AA) and radioactive prostanoids were purchased from Amersham Biosciences (Buckinghamshire, UK). Acetonitrile and other organic solvents were obtained from Merck (Darmstadt, Germany). Unless stated otherwise, all other chemicals were purchased from Sigma-Aldrich Co.
2.2. Recombinant Adenovirus (Ad)
Replication-defective first generation E1-deleted adenoviral vectors were used. Adenovirus encoding GFP (expressing the green fluorescence protein of jelly fish), PGI2 synthase (PGIS), or bicistronic COX-1/PGIS used phosphoglycerate kinase (PGK) as a driving promoter. The preparation, ex vivo expansion, and purification of these Ads followed methods described previously [18, 20, 21]. The viral titers of the purified Ads were determined by a plaque-forming assay and were in the range of ~1010 pfu/mL.
2.3. Cell Cultures and In Vitro Transduction
Mixed neuronal/glial cell cultures were prepared from the mesencephalic region of embryonic Sprague-Dawley (SD) rat fetus at gestation of 14–16 days as described in Tsai et al. [22, 23]. Briefly, cells were dissociated with mixtures of papain/protease/deoxyribonuclease I (0.1% : 0.1% : 0.03%) and plated onto poly-D-lysine coated dishes at a density of 1~2 × 105 cells/cm2 in DMEM supplemented with 10% FBS. Second day after cell seeding, cultures were infected with AdGFP, AdCOX-1 or AdCOX-1/PGIS. Neuronal cells in the mixed neuron/glial cultures were identified by immunostaining against anti-III tubulin (dilution 1/300; Covance, CA, USA). Mixed glial cells were prepared from neonatal rat brains as described previously [24, 25]. Briefly, triturated cortexes, free of vessels and meninges, were passed through nylon cloths and plated in 75 cm2 flasks in DMEM supplemented with 10% FBS. The cells were incubated at 37°C in a water-saturated atmosphere of 5% CO2/95% air. When cell reached confluence, cells in the flasks were subcultured and replated into multiwell plates. Cultures showed greater than 90% positive staining for glial fibrillary acidic protein (rabbit or mouse anti-GFAP, Chemi-Con, USA), an astroglial marker. Subconfluent cultures were used for measure of proliferative activity (tritiated thymidine incorporation or MTT reduction; see below), while confluent cultures were used for assay of metabolic activity in response to 14C-arachidonic acid (AA). For in vitro transduction, cells were fed with growth medium. Ad-GFP, Ad-PGIS, or Ad-COX-1/PGIS was added to cultured cells with a multiplicity of infection (MOI, pfu/cell) of 20. Recombinant Ad-GFP was used as a vector control and for optimizing the infection conditions. Three days after Ads transduction, cells were processed for eicosanoid measurement or treated with LPS (600 ng/mL) for 2 days. The culture medium was then assayed for nitric oxide (NO), and the cells were processed for western blot analysis. CAY10449 at 500 nM was added to mixed glial cells at 2 hr after AdPGIS transduction. Cultures were incubated for 5 days with medium and drug refilled once. Cultures were then processed for MTT reduction.
2.4. Extraction and Analysis of Arachidonic Acid (AA) Metabolites in Mixed Glial Culture and in Mixed Neuron/Glial Cultures
Confluent glial cultures or neuron/glial cultures after AdGFP, AdPGIS AdCOX-1, or AdCOX-1/PGIS transduction were measured for AA metabolic activity. Briefly, cultured cells were incubated in DMEM (serum-free) containing 10 M [1-14C] AA at 37°C for 10 min. The cells were saved for western blot analysis, while the released fractions, containing radioactive eicosanoids, were extracted by a Sep-Pak C18 cartridge (Waters Associates, Milford, MA) as described [20, 21]. The resulted extracts of 14C-labeled AA metabolites (eicosanoids) were analyzed by reverse phase high performance liquid chromatography (HPLC; Waters model 2690) equipped with an online radioisotope detector (Packard 150-TP) as previously described . Briefly, the stationary phase was Inertsil 7 ODS-3 (4.6 × 150 mm; Vercopak, Taiwan). The mobile phase consisted of programmed gradient elution between solvent A (acetonitrile) and solvent B (0.1% acetic acid, pH 3.7) at a flow rate of 1 mL/min as follows: 34% B for 10 min, 34–40% B within 4 min, 40–50% B within 1 min, 50% B for 5 min, 50–75% B within 10 min, 75–100% B within 10 min, and 100% B for 10 min. The eicosanoids were identified by their retention times with the authentic radioisotope standards.
2.5. [H]-Thymidine Incorporation Assay
The proliferative activity of mixed glial cultures after Ad transduction was investigated in subconfluent cultures by pulse of cultures with 0.5 Ci/mL [3H]-thymidine for 10 hrs according to our previous methods [26, 27]. After [3H]-thymidine pulse, cultured media were carefully removed and cells were washed twice with PBS. Aliquot of ice-cold 10% trichloroacetic acid (250 L/well) was added to cells. The radioactivities in the cell lysate were measured in a scintillation counter.
2.6. 6-OHDA Lesion
Adult SD rats weighing 250–300 g were used. The animals were anesthetized by isoflurane (1-chloro-2,3,4-trifluoroethyl ether, Aerrane) with oxygen during surgery. Operations were carried out using an operating microscope under aseptic conditions. All procedures involving animals were approved by the Animals Committee of Taipei Veterans General Hospital. Surgical procedures, postoperative care, and monitoring have been described previously [28–30]. Unilateral 6-OHDA lesion of nigrostriatal pathway was performed with the rats under isoflurane anesthesia by stereotaxic injection of 6-OHDA HBr [20 g/rat; dissolved in ascorbate (0.02% in PBS as vehicle)]. Five microliters of 6-OHDA (2 g/L) were injected into two sites (5 L/site) in the ascending nigrostriatal pathway near the MFB of adult SD rats as described . The coordinates of two MFB injections were AP-4.2 mm (posterior to bregma), ML-1.1 mm (lateral to the midline), DV-7.8 mm (7.8 mm below the dura), AP-4.4 mm (posterior to bregma), ML-0.9 mm, and DV-7.8 mm. The needle was allowed to remain in the brain for 5 min before being retracted at the end of the 6-OHDA infusion.
2.7. Intranigral Injection of Ad Vectors
After the rat was placed in the stereotaxic frame (Kopf Instruments, Tujunga, CA) infused with saline or 6-OHDA, injection of Ad vector to brain regions was conducted. 1 L Ad vector suspended in PBS was injected into the vicinity of the SN at [coordinate AP −5.3 mm, ML −2.1 mm, and DV −7.2 mm from bregma] or into striatum at [AP+0.5 mm; ML+2.0 mm and DV−5.0 mm from bregma]. Ad injection was through a 5 L Hamilton syringe fitted with a 30-gauge beveled hypodermic needle for 5 min at a rate of 0.2 L/min. After the cessation of the injection, the needle was left in place for 5 min before being slowly withdrawn from the brain. Ad vector injection was conducted within 30 min after infusion of 6-OHDA to MFB.One microliter of storage buffer, Ad-GFP, or AdCOX-1/PGIS containing approximately plaque-forming units (pfu) was injected. AdGFP was used as a mock control and for examining infective tropism.
2.8. Apomorphine-Induced Circling Behavior
One to four weeks after the infusion of 6-OHDA and Ads, a behavioral test was conducted to identify the efficacy of treatment. Rats from all groups were administered with the DA agonist apomorphine (0.5 mg/kg, s.c.) and immediately separated into individual acrylic box cages. Ten minutes later, the number of contralateral rotations to the lesioned side was recorded in each rat every 5 min for a total time of 60 min. Each rotation was defined as a complete 360° turn. Results were expressed as the total number of turns that rats completed in 60 min. In the present study, rats with 6-OHDA lesion only would have a net contralateral rotational asymmetry of 500 turns/hr.
2.9. Biochemical Assays
The production of nitric oxide (NO), as nitrite accumulation, was assayed in the medium using colorimetric reaction with Griess reagents (1% sulfanilamide/0.1% naphthyl ethylene diamine dihydrochloride/2% phosphoric acid) as described . The degree of MTT reduction was used to measure cell viability or proliferative activity. Following treatment, MTT was added to cultured cells at final concentration of 0.1 mg/mL and reacted with the surviving cells for 4 hr at 37°C. The resulted blue formazan product was solubilized and measured at an absorbance of 570 nm .
Rats were perfused intracardially with 4% paraformaldehyde in PBS under deep anesthesia with sodium pentobarbital at the end of the experiments. The brains were removed, postfixed in 4% paraformaldehyde overnight, and then cryoprotected in PBS containing 30% (w/v) sucrose for 3 days. The tissues were excised and embedded in Tissue Tek OCT (Sakura Fine Technical, Tokyo, Japan) and then cross-sectioned at 20 m thickness with a cryostat. Tissue sections were collected onto glass slides and dried at 37°C. The tissue sections were incubated with primary antibodies, followed by respective 2nd antibodies for histological evaluation as described [30, 32]. To examine the infective tropism of AdGFP, rats were processed for histological analysis at three days after nigral AdGFP infection. Double immunostaining of GFP with cell markers was conducted in coronal brain sections. Antibodies for cell markers included anti-tyrosine hydroxylase (TH) (mouse, dilution 1/150, Chemicon, Temecula, CA) for dopamine neurons, anti-GFAP (rabbit, dilution 1/1000; Chemicon, Temecula, CA) for astrocytes, Biotinylated Griffonia simplicifolia lectin I isolectin B4 (biotinylated GSLI-IB4, dilution 1/100; vector b1205), or anti-ED-1 (mouse, dilution 1/250; Serotec, Oxford, UK) for microglia.
2.11. Western Blot Analysis
Brain tissues or cultured cells were solubilized in lysis buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, 40 mM Tris buffer, pH7.5, protease inhibitors (Roche, Mannheim, Germany), 1 mM PMSF, 1 mM Na3VO4, and 1 mM DTT. Protein concentration of the resultant lysate was determined using Bio-Rad protein assay (Bio-Rad, Hercules, CA). Equal amounts of proteins were loaded and separated using 8%–12% gels (SDS-PAGE) as described . After electrophoresis, proteins in the gels were transferred to PVDF membranes (Millipore Corp., USA) and incubated overnight at 4°C with antibodies against PGIS (rabbit, dilution 1/3000), COX-2 (rabbit, dilution 1/5000, Cayman), inducible nitric oxide synthetase (iNOS, mouse, dilution 1/5000, BD Bioscience, USA), or -actin (goat, dilution 1/5000, Santa Cruz Biotech, USA) followed by a horseradish peroxidase-conjugated secondary antibody (dilution 1/2000, Jackson Lab) for 1 hr at room temperature. Immunoreactivity was visualized by enhanced chemiluminescent detection (Perkin Elmer Co., USA).
3.1. Analysis of Eicosanoids Produced by Cultured Glial Cells in Response to [1-C] AA Treatment
Purified Ads were successfully expanded and purified before conducting the in vitro and in vivo experiments. Highly purified adenoviruses encoding GFP, PGIS, and bicistronic COX-1/PGIS, ranging from 1010~1011 pfu/mL, were used in the present study. Previously, we have demonstrated high permissivity of mixed glial cultures to AdGFP infection . Almost all cells expressed GFP at 2 days after 20 MOIs of Ad-GFP transduction (Similar results are shown in Figure 4(f)). In the present study, we directly examined the activities of eicosanoid biosynthetic activity in Ad-transduced mixed glial cells in response to C-AA pulse. Because mixed glial cultures are depleted of neuronal cells, studying AA metabolic activity in glia cultures would give some clue to the relative roles of neurons versus glial cells. We incubated cultures with [1-14C] AA for 10 min, extracted eicosanoids from the medium by a C18 cartridge, and analyzed the eicosanoids by HPLC. Two predominant peaks, prostaglandin (PG) and PGD2, were detected in nontreated cultures (Figure 1(a)). Very little or none of PGI2 (prostacyclin), shown as its hydrolysis product 6-keto-PGF1α (6KP), was found. The transduction of AdGFP did not alter the metabolic profile (data not shown). The 6-keto-PGF1α peak was mostly reduced (80%) when cells were pretreated with NS398, a selective COX-2 inhibitor (Figure 1(b)). Furthermore, no 6-keto-PGF1α peak was detected when cells were pretreated with indomethacin, an inhibitor for both COX-1 and COX-2. This indicates COX-2 as the major enzyme of eicosanoid synthesis in mixed glial cultures in response to 14C-AA. Interestingly, AA metabolites were shunted through prostacyclin synthesis on AdPGIS transduction. Very little of PGE2 and PGD2 remained in AdPGIS-transduced cultures. This indicates that the overexpressing enzyme was functionally active in producing prostacyclin from AA. By contrast, AdPGIS-infected neuron/glial cultures did not augment 6-keto-PGF1α synthesis (see Supplementary Figure 1 available online at http://dx.doi.org/10.1155/2013/649809 and Tsai et al., ). AdCOX-1-infected neuron/glial cultures produced predominant PGE2 and PGD2 peaks. Only bicistronic AdCOX-1/PGIS-infected neuron/glial cultures prominently enhanced 6-keto-PGF1α synthesis.
3.2. Enhanced Prostacyclin Synthesis Reduced Cell Proliferation and LPS Stimulation in Mixed Glial Cells
To examine the effects of enhanced prostacyclin synthesis on cell proliferation, subconfluent glial cells were transduced with Ad-PGIS for 2 days. Tritiated thymidine was added to cultures 10 hr before cell harvest. Table 1 shows that overexpression of PGIS in cultured glial cells concurrently enhanced prostacyclin production (indicated by level of 6-keto-PGF1α, the product of PGI2 hydrolysis) and inhibited astroglial proliferation (indicated by thymidine incorporation). To examine whether the effect of overexpressing PGIS on cell proliferation was mediated via IP (prostacyclin) receptor, CAY10449 was added to mixed glial cells at 2 hr after AdPGIS transduction. As shown in Figure 2, AdPGIS transduction reduced degree of MTT reduction in mixed glial cultures. The high-affinity IP antagonist, CAY10449, at 500 nM partially but significantly abrogated prostacyclin effect on cell proliferation. LPS is a powerful immune challenge. LPS treatment has been shown to induce release of cytokines, NO, and proinflammatory factors from macrophages [34, 35]. Effect of overexpressing PGIS on LPS stimulation was examined in mixed glial cultures. Confluent glial cultures were transduced with AdGFP or AdPGIS. Three days later, cells were further treated with LPS at a dose of 600 ng/mL for 2 days. In our previous paper , we used 100 ng/mL LPS to stimulate neuron/glial cultures. However, LPS failed to affect mixed glial cells at 100 ng/mL and required higher concentration of LPS for effective cell stimulation. As shown in Figure 3, Ad-PGIS transduction enhanced the expression of PGIS whereas iNOS and COX-2 levels were barely detectable. By contrast, LPS treatment induced increase of iNOS and COX-2 expression in control and AdGFP-infected cells. AdPGIS transduction effectively reduced LPS-induced COX-2 and iNOS levels. Concurrently, LPS-stimulated nitrite releases were significantly inhibited in AdPGIS-transduced cells (Figure 3(b)) compared to control and Ad-PGK-infected cells. This indicates that enhanced prostacyclin synthesis in PGIS-overexpressing cells significantly inhibited iNOS expression and NO production.
3.3. Infective Tropism of AdGFP Transduction in Mesencephalic Neuron/Glial Cultures and in Rat Substantia Nigra (SN)
First, we examined the infective tropism of AdGFP in mesencephalic neuron/glial cultures which were enriched with DA neurons. AdGFP (~106 pfu/well each) was added to cultured cells in serum or serum-free medium. As shown in Figure 4, AdGFP predominantly transduced nonneuronal cells. In serum-free condition, the AdGFP infective cells were % astroglial (GFAP-positive) cells, % microglia (ED1-positive) cells, and % NG2-positive cells. No III tubulin-positive neuron or TH-positive DA neurons showed GFP immunoreactivity. Furthermore, the AdGFP infective efficiency in serum-containing medium (10% FCS) was reduced compared to that in serum-free condition. Using same titer of AdGFP to neuron/glial culture, GFP-positive cells in cultures maintained in serum-free and serum-containing conditions were and cells/mm2, respectively. We further performed double-labelled staining for AdGFP-infected coronal sections containing SN. After injection of AdGFP into the normal SN, the expression of GFP was observed along the site of injection. Figure 5 shows the representative micrographs of double-labelled immunostaining results. Some GFP-positive cells in the SN were also positively stained for TH, which denote dopaminergic neurons (Figure 5(a), arrow). Some GSLI-IB4-positive microglia (in Figure 5(b), arrow head) seemed to be immunoreactive to GFP. By contrast, almost no double-labelled staining cells were found in GFP with GFAP or nestin immunoreactivity (Figures 5(c) and 5(d)). These results showed that transgene expression could be achieved in neurons or microglia after injection of AdGFP into the SN in vivo. The results of AdGFP tropism in cultures and in SN were not consistent. We also infected AdGFP to the striatum and examined the infective tropism (shown in Supplementary Figure 2). Consistent with the results observed in AdGFP-infected SN in vivo, TH-positive, GFAP-positive, ED1-positive and nestin-positive cells were found to be double labelled with GFP in rat striatum.
3.4. Effect of Nigral Infusion of Ad-COX-1/PGIS in Hemiparkinsonian Rats
Our previous study showed that bicistronic AdCOX1/PGIS infection to neuron/glial cultures produced prominent prostacyclin synthesis, whereas AdPGIS infection did not . We thus directly infused AdCOX-1/PGIS to rat SN for ensured prostacyclin production. 6-OHDA at a dose of 20 g/rat was infused to the right MFB in rats. Within 30 minutes after 6-OHDA infusion, AdGFP or AdCOX1/PGIS ( pfu) was subsequently infused to right SN. Behavioral test was examined weekly after surgery by apomorphine-induced turning. Rats were sacrificed 4 weeks after treatment. Regions of substantia nigra and striatum were microdissected for dopamine level measurement. Figures 6(a) and 6(b) demonstrate 6-OHDA treatment severely depleted TH-positive neurons in right SN compared with untreated left site. Some TH-positive neurons were rescued by AdCOX1/PGIS gene transfer (Figure 6(c)). Treatment rescued TH-positive neurons ipsilateral to gene delivery. In all cases, Ad treatment had no effect on the contralateral SN. Apomorphine-induced turning behaviors, as a marker of motor impairment, in 6-OHDA-lesioned rats were shown in Figure 6(d). 6-OHDA-treated rats displayed a considerable number of rotations. And this effect was significantly reduced in rats transduced with AdCOX1/PGIS (). The group treated with AdGFP transduction produced no significant changes in rotation behavior when compared with 6-OHDA lesion only. Taken together, nigral Ad-COX-1/PGIS infection protected against 6-OHDA-induced dopaminergic damage and behavioral deficits.
Adenovirus-mediated gene transfer is a promising tool for the treatment of neurodegenerative diseases. Recombinant adenoviral vectors target gene expression to the nervous system and offer prolonged expression of foreign proteins [23, 33, 36]. Here, we present evidence that glial cultures, mesencephalic neuron/glial cultures, or nigral dopaminergic neurons (SNpc) could effectively be infected by recombinant adenoviruses and thereby expressing transgenes. Our data with glial cultures demonstrated that unstimulated cells actively metabolized exogenous AA into PGE2 and PGD2. These PGs were largely NS398 sensitive and therefore considered as COX-2-derived products. This was in contrast to low AA metabolic activity in neuronal cells, which released barely detected eicosanoids . Interestingly, gene transfer of Ad-PGIS to glial cultures effectively shunted the AA catabolism through synthesis of 6-keto-PGF1α, a hydrolyzed product of prostacyclin. This indicates that the overexpressing enzyme was functionally active in cooperation with endogenous COX to produce prostacyclin. Accordingly, enhanced prostacyclin production effectively inhibited glial proliferation, in part, through prostacyclin IP receptor. Furthermore, enhanced prostacyclin synthesis significantly inhibited LPS stimulation through inhibition of COX-2 and iNOS expression and NO production. Cell viabilities, measured as LDH release in medium, were not affected by Ad infection or LPS treatment (data not shown).
It is well known that LPS, a major component of the outer membrane of Gram-negative bacteria, induces inflammatory response through cytokine production . We found that mixed glial cells were less sensitive to LPS stimulation in comparison to mixed neuron-glial cultures. LPS is a powerful tool for the activation of microglia. Although LPS has no known direct toxic effect on neurons, it activates microglia to release neurotoxic factors [38, 39]. Neurons, through mechanisms of cell-cell interaction, also modulate the reactivity of microglia [40, 41]. In the present study, AA metabolic activities in neuron/glial culture and in glial cultures were quite different, highlighting the involvement of cell-cell interaction. This work aims to examine the effect of PGI2 in nervous system. Our previous results have shown that overexpression of COX-1 and PGIS is able to generate large quantity of PGI2 . AdCOX-1 infected cells could overexpress COX-1 with consistent high activity (mainly PGE2), as shown in Supplementary Figure 1 in which 14C-labelled eicosanoids were generated by Ad COX-1-infected neuron/glial cultures in response to [1-14C] AA treatment. Therefore, we used the Ad-COX-1/PGIS to investigate the effect of enhanced PGI2 synthesis in substantia nigra in vivo. Both COX-1 and COX-2 catalyze conversion of AA to PGG2 and further convert to PGH2. It is possible that overexpression of COX-2/PGIS will generate large quantity of PGI2 as well.
Our data with adenoviral gene transfer in rat SN indicate that recombinant adenovirus could infect both dopaminergic neurons and microglia efficiently. Among GFP-expressing cells in SN, % were TH-positive dopamine neurons and % were microglia. The transgene expression was not found in GFAP- or nestin-positive cells, in contrast to that seen in mesencephalic neuron/glial cultures. Figure 4 shows that AdGFP preferentially infected NG2(+) cells, ED1(+) and GFAP(+) cells, while no beta III tubulin (+) neurons or TH(+) dopamine neurons were infected in mixed neuron/glial cultures. High permissivity to AdGFP transduction in mixed glial cells was also shown. Because mixed glial or neuron/glial cultures were maintained as monolayer cultures, nonneuronal cells in these cultures extended and flattened, allowing high probability of getting AdGFP infection. While SN is enriched with DAergic cell body and particularly rich in microglia [2, 3], targeting AdGFP injection to SN in vivo was possible to be taken up by microglia and by large area of DA dendrites in situ. Thus, rare GFAP/GFP double-labelled cells could be found. Our previous study showed that bicistronic AdCOX1/PGIS infection to neuronal cultures produced prominent prostacyclin synthesis . This was also true in endothelial cells that the overexpressed PGIS and COX-1 were colocalized, leading to monophasic overexpression of prostacyclin . We thus directly infused AdCOX-1/PGIS to rat SN for ensured prostacyclin production. Figure 6 showed that overexpression of COX1/PGIS reduced dopaminergic neuronal death induced by 6-OHDA. We provide evidence that a decrease of the number of TH-positive cells at 4 weeks after 6-OHDA lesion corresponds well with rotational behavior. 6-OHDA-treated rats displayed a considerable number of rotations. This effect was significantly attenuated in rats transduced with AdCOX1/PGIS (). The 6-OHDA lesion group with AdGFP transduction produced no significant changes in rotation behavior when compared with 6-OHDA lesion only. Taken together, nigral Ad-COX-1/PGIS infection ameliorated 6-OHDA-induced dopaminergic damage and behavioral deficits.
We used first-generation E1-deleted Ad vectors in the present study. Possible neurotoxic effects induced by Ad expression should be considered. Although we did not evaluate immune response in this study, there were no significant side effects in rats with Ad injection. Furthermore, AdPGIS, AdCOX-1/PGIS or AdGFP used in this study had been constructed with a PGK promoter that could drive prolonged (days to weeks) transgene expression. The mechanisms by which AdPGIS-transduction reduced glial activation or AdCOX1/PGIS-transduction reduced Parkinsonian dysfunction have not yet been clarified. In the brain, at least two distinct prostacyclin receptors, designated as IP1 and IP2, have been shown . The IP2 receptor was found only in the CNS and thus named as central-type prostacyclin receptor . The IP1 receptor is mainly coupled to G-protein-coupled receptor. Stimulation of the receptor results in cAMP production . It remains to be determined which receptor subtype (IP1 or IP2) is involved in this effect. Further studies are needed to elucidate the role played by downstream molecules in the inhibition of cell proliferation and LPS stimulation and in protection to hemiparkinsonism.
In conclusion, this study shows that enhanced prostacyclin synthesis by adenovirus-mediated gene transfer of AdPGIS or AdCOX1/PGIS reduced glial activation and ameliorated motor dysfunction in hemiparkinsonian rats. We suggest that prostacyclin may have a neuroprotective role in modulating the inflammatory response in degenerating nigra-striatal pathway.
S.-K. Shyue and H. Cheng contributed equally to this work.
This work was supported by Grants V101E6-001 and CI-95-5 from the Taipei Veterans General Hospital in Taiwan, by a Grant NSC 91-2320-B-075-017 from the National Science Council in Taiwan, and by a Grant from the Ministry of Education (Aim for the Top University Plan).
- E. G. McGeer and P. L. McGeer, “The importance of inflammatory mechanisms in Alzheimer disease,” Experimental Gerontology, vol. 33, no. 5, pp. 371–378, 1998.
- L. J. Lawson, V. H. Perry, P. Dri, and S. Gordon, “Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain,” Neuroscience, vol. 39, no. 1, pp. 151–170, 1990.
- W. G. Kim, R. P. Mohney, B. Wilson, G. H. Jeohn, B. Liu, and J. S. Hong, “Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia,” Journal of Neuroscience, vol. 20, no. 16, pp. 6309–6316, 2000.
- P. L. McGeer, C. Schwab, A. Parent, and D. Doudet, “Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration,” Annals of Neurology, vol. 54, no. 5, pp. 599–604, 2003.
- F. Cicchetti, A. L. Brownell, K. Williams, Y. I. Chen, E. Livni, and O. Isacson, “Neuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imaging,” European Journal of Neuroscience, vol. 15, no. 6, pp. 991–998, 2002.
- A. Castaño, A. J. Herrera, J. Cano, and A. Machado, “The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α IL-1β IFN-γ,” Journal of Neurochemistry, vol. 81, no. 1, pp. 150–157, 2002.
- A. J. Herrera, A. Castaño, J. L. Venero, J. Cano, and A. Machado, “The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system,” Neurobiology of Disease, vol. 7, no. 4, pp. 429–447, 2000.
- M. Feldman, K. Shewmake, and B. Cryer, “Time course inhibition of gastric and platelet COX activity by acetylsalicylic acid in humans,” American Journal of Physiology, vol. 279, no. 5, pp. G1113–G1120, 2000.
- P. N. Rocha, T. J. Plumb, and T. M. Coffman, “Eicosanoids: lipid mediators of inflammation in transplantation,” Springer Seminars in Immunopathology, vol. 25, no. 2, pp. 215–227, 2003.
- C. D. Breder, D. Dewitt, and R. P. Kraig, “Characterization of inducible cyclooxygenase in rat brain,” Journal of Comparative Neurology, vol. 355, no. 2, pp. 296–315, 1995.
- K. Seibert and J. L. Masferrer, “Role of inducible cyclooxygenase (COX-2) in inflammation,” Receptor, vol. 4, no. 1, pp. 17–23, 1994.
- R. Brambilla, G. Burnstock, A. Bonazzi, S. Ceruti, F. Cattabeni, and M. P. Abbracchio, “Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis,” British Journal of Pharmacology, vol. 126, no. 3, pp. 563–567, 1999.
- L. Minghetti, A. Nicolini, E. Polazzi, C. Creminon, J. Maclouf, and G. Levi, “Inducible nitric oxide synthase expression in activated rat microglial cultures is downregulated by exogenous prostaglandin E2 and by cyclooxygenase inhibitors,” GLIA, vol. 19, no. 2, pp. 152–160, 1997.
- S. Moncada and J. R. Vane, “The role of prostacyclin in vascular tissue,” Federation Proceedings, vol. 38, no. 1, pp. 66–71, 1979.
- T. Satoh, Y. Ishikawa, Y. Kataoka et al., “CNS-specific prostacyclin ligands as neuronal survival-promoting factors in the brain,” European Journal of Neuroscience, vol. 11, no. 9, pp. 3115–3124, 1999.
- Y. Cui, Y. Kataoka, T. Satoh et al., “Protective effect of prostaglandin I2 analogs on ischemic delayed neuronal damage in gerbils,” Biochemical and Biophysical Research Communications, vol. 265, no. 2, pp. 301–304, 1999.
- S. Naredi, M. Olivecrona, C. Lindgren, A. L. Östlund, P. O. Grände, and L. O. D. Koskinen, “An outcome study of severe traumatic head injury using the “Lund therapy” with low-dose prostacyclin,” Acta Anaesthesiologica Scandinavica, vol. 45, no. 4, pp. 402–406, 2001.
- S. K. Shyue, M. J. Tsai, J. Y. Liou, J. T. Willerson, and K. K. Wu, “Selective augmentation of prostacyclin production by combined prostacyclin synthase and cyclooxygenase-1 gene transfer,” Circulation, vol. 103, no. 16, pp. 2090–2095, 2001.
- H. Lin, T. N. Lin, W. M. Cheung et al., “Cyclooxygenase-1 and bicistronic cyclooxygenase-1/ prostacyclin synthase gene transfer protect against ischemic cerebral infarction,” Circulation, vol. 105, no. 16, pp. 1962–1969, 2002.
- M. J. Tsai, S. K. Shyue, C. F. Weng et al., “Effect of enhanced prostacyclin synthesis by adenovirus-mediated transfer on lipopolysaccharide stimulation in neuron-glia cultures,” Annals of the New York Academy of Sciences, vol. 1042, pp. 338–348, 2005.
- J. Y. Liou, S. K. Shyue, M. J. Tsai, C. L. Chung, K. Y. Chu, and K. K. Wu, “Colocalization of prostacyclin synthase with prostaglandin H synthase-1 (PGHS-1) but not phorbol ester-induced PGHS-2 in cultured endothelial cells,” Journal of Biological Chemistry, vol. 275, no. 20, pp. 15314–15320, 2000.
- M. J. Tsai, Y. M. A. Chen, C. F. Weng et al., “Enhanced expression of glycine N-methyltransferase by adenovirus-mediated gene transfer in CNS culture is neuroprotective,” Annals of the New York Academy of Sciences, vol. 1199, pp. 194–203, 2010.
- M. J. Tsai, C. F. Weng, S. K. Shyue et al., “Dual effect of adenovirus-mediated transfer of BMP7 in mixed neuron-glial cultures: neuroprotection and cellular differentiation,” Journal of Neuroscience Research, vol. 85, no. 13, pp. 2950–2959, 2007.
- M. J. Tsai and E. H. Lee, “Characterization of L-DOPA transport in cultured rat and mouse astrocytes,” Journal of Neuroscience Research, vol. 43, pp. 490–495, 1996.
- M. J. Tsai and E. H. Y. Lee, “Nitric oxide donors protect cultured rat astrocytes from 1-methyl-4- phenylpyridinium-induced toxicity,” Free Radical Biology and Medicine, vol. 24, no. 5, pp. 705–713, 1998.
- M. J. Tsai, C. C. Goh, Y. L. Wan, and C. Chang, “Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization,” Neuroscience, vol. 79, no. 3, pp. 819–826, 1997.
- C. J. Yang, Y. J. Huang, C. Y. Wang et al., “Antiproliferative effect of Toona sinensis leaf extract on non-small-cell lung cancer,” Translational Research, vol. 155, no. 6, pp. 305–314, 2010.
- H. Cheng, S. Almström, L. Giménez-Llort et al., “Gait analysis of adult paraplegic rats after spinal cord repair,” Experimental Neurology, vol. 148, no. 2, pp. 544–557, 1997.
- H. Cheng, Y. Cao, and L. Olson, “Spinal cord repair in adult paraplegic rats: partial restoration of hind limb function,” Science, vol. 273, no. 5274, pp. 510–513, 1996.
- H. S. Kuo, M. J. Tsai, M. C. Huang et al., “The combination of peripheral nerve grafts and acidic fibroblast growth factor enhances arginase I and polyamine spermine expression in transected rat spinal cords,” Biochemical and Biophysical Research Communications, vol. 357, no. 1, pp. 1–7, 2007.
- F. C. Zhou, Y. H. Chiang, and Y. Wang, “Constructing a new nigrostriatal pathway in the Parkinsonian model with bridged neural transplantation in substantia nigra,” Journal of Neuroscience, vol. 16, no. 21, pp. 6965–6974, 1996.
- M. J. Tsai, J. F. Liao, D. Y. Lin et al., “Silymarin protects spinal cord and cortical cells against oxidative stress and lipopolysaccharide stimulation,” Neurochemistry International, vol. 57, no. 8, pp. 867–875, 2010.
- M. J. Tsai, H. A. Pan, D. Y. Liou, C. F. Weng, B. J. Hoffer, and H. Cheng, “Adenoviral gene transfer of bone morphogenetic protein-7 enhances functional recovery after sciatic nerve injury in rats,” Gene Therapy, vol. 17, no. 10, pp. 1214–1224, 2010.
- H. Y. Hsu and M. H. Wen, “Lipopolysaccharide-mediated reactive oxygen species and signal transduction in the regulation of interleukin-1 gene expression,” Journal of Biological Chemistry, vol. 277, no. 25, pp. 22131–22139, 2002.
- S. Sanlioglu, C. M. Williams, L. Samavati et al., “Lipopolysaccharide induces rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-α secretion through IKK regulation of NF-κB,” Journal of Biological Chemistry, vol. 276, no. 32, pp. 30188–30198, 2001.
- R. S. Slack and F. D. Miller, “Viral vectors for modulating gene expression in neurons,” Current Opinion in Neurobiology, vol. 6, no. 5, pp. 576–583, 1996.
- S. Wang, M. Miura, Y. K. Jung, H. Zhu, E. Li, and J. Yuan, “Murine caspase-11, an ICE-interacting protease, is essential for the activation of ICE,” Cell, vol. 92, no. 4, pp. 501–509, 1998.
- E. Araki, C. Forster, J. M. Dubinsky, M. E. Ross, and C. Iadecola, “Cyclooxygenase-2 inhibitor NS-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity,” Stroke, vol. 32, no. 10, pp. 2370–2375, 2001.
- D. M. Bronstein, I. Perez-Otano, V. Sun et al., “Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures,” Brain Research, vol. 704, no. 1, pp. 112–116, 1995.
- R. C. C. Chang, W. Chen, P. Hudson, B. Wilson, D. S. K. Han, and J. S. Hong, “Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS,” Journal of Neurochemistry, vol. 76, no. 4, pp. 1042–1049, 2001.
- R. C. C. Chang, P. Hudson, B. Wilson, L. Haddon, and J. S. Hong, “Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-α by cultured glia,” Brain Research, vol. 853, no. 2, pp. 236–244, 2000.
- H. Takechi, K. Matsumura, Y. Watanabe et al., “A novel subtype of the prostacyclin receptor expressed in the central nervous system,” Journal of Biological Chemistry, vol. 271, no. 10, pp. 5901–5906, 1996.
- T. Namba, H. Oida, Y. Sugimoto et al., “cDNA cloning of a mouse prostacyclin receptor. Multiple signaling pathways and expression in thymic medulla,” Journal of Biological Chemistry, vol. 269, no. 13, pp. 9986–9992, 1994.